EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSOTSG00005019345
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOTSG00005032102
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:

Kinesin-Like Protein Kif11

Ensembl ID : ENSOTSG00005027679
Gene Symbol: LOC112255246
3 Cross references
196 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSOTSG00005044207
Gene Symbol: LTA4H
1 Cross references
199 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSOTSG00005031020
Gene Symbol: LOC112254085
2 Cross references
151 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSOTSG00005021701
Gene Symbol: LTB4R2A
1 Cross references
151 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOTSG00005037238
Gene Symbol: LTB4R2B
1 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOTSG00005012161
Gene Symbol: LTB4R2B
1 Cross references
161 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOTSG00005036885
Gene Symbol: KDM1A
1 Cross references
205 Possible Orthologues:

Lysine-Specific Histone Demethylase 1a-Like

Ensembl ID : ENSOTSG00005022157
Gene Symbol: LOC112256467
3 Cross references
207 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSOTSG00005005180
Gene Symbol: LOC112215566
3 Cross references
204 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSOTSG00005027818
Gene Symbol: LOC112248680
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).